Subantimicrobial Dose Doxycycline Worsens Chronic Arthritis-Induced Bone Microarchitectural Alterations in a Mouse Model: Role of Matrix Metalloproteinases?
暂无分享,去创建一个
T. Kiss | P. Ferdinandy | A. Mócsai | Z. Helyes | P. Bencsik | A. Felinger | B. Botz | K. Csekő | Éva Kenyeres | I. Kiss | Á. Horváth | T. Szabados | Kata Csekő
[1] D. Kosson,et al. Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism , 2018, Drug design, development and therapy.
[2] G. Fields,et al. Matrix metalloproteinase collagenolysis in health and disease. , 2017, Biochimica et biophysica acta. Molecular cell research.
[3] B. Fingleton. Matrix metalloproteinases as regulators of inflammatory processes. , 2017, Biochimica et biophysica acta. Molecular cell research.
[4] D. Walsh,et al. Pain mechanisms in rheumatoid arthritis. , 2017, Clinical and experimental rheumatology.
[5] G. Viana,et al. Doxycycline induces bone repair and changes in Wnt signalling , 2017, International Journal of Oral Science.
[6] P. Mátyus,et al. Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse , 2017, Scientific Reports.
[7] I. McInnes,et al. Rheumatoid arthritis , 2016, The Lancet.
[8] D. Kooyman,et al. A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology , 2016, Disease markers.
[9] M. Jougasaki,et al. Matrix Metalloproteinases in Non-Neoplastic Disorders , 2016, International journal of molecular sciences.
[10] L. Golub,et al. Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. , 2016, International dental journal.
[11] J. Szolcsányi,et al. Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice , 2016, Arthritis Research & Therapy.
[12] P. Ferdinandy,et al. Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients , 2015, European journal of clinical investigation.
[13] T. Kiss,et al. Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis , 2015, Brain, Behavior, and Immunity.
[14] J. Nyman,et al. Effects of long-term doxycycline on bone quality and strength in diabetic male DBA/2J mice , 2015, Bone reports.
[15] A. Kuliopulos,et al. Mouse Matrix Metalloprotease‐1a (Mmp1a) Gives New Insight Into MMP Function , 2014, Journal of cellular physiology.
[16] V. Geoffroy,et al. Dkk‐1–Mediated Inhibition of Wnt Signaling in Bone Ameliorates Osteoarthritis in Mice , 2014, Arthritis & rheumatology.
[17] A. Dufour,et al. Macrophage matrix metalloproteinase-12 dampens inflammation and neutrophil influx in arthritis. , 2014, Cell reports.
[18] A. Mócsai,et al. Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model , 2014, Arthritis & rheumatology.
[19] S. Rankin,et al. Antibiotic administration in the drinking water of mice. , 2014, Journal of the American Association for Laboratory Animal Science : JAALAS.
[20] P. Ferdinandy,et al. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective. , 2014, Pharmacological research.
[21] P. Angel,et al. Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis , 2013, Arthritis Research & Therapy.
[22] A. Gibofsky,et al. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. , 2012, The American journal of managed care.
[23] R. Greenwald. The road forward: the scientific basis for tetracycline treatment of arthritic disorders. , 2011, Pharmacological research.
[24] C. López-Otín,et al. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model , 2010, Arthritis research & therapy.
[25] R. Kappelhoff,et al. Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression. , 2010, Arthritis and rheumatism.
[26] C. Svensson,et al. Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis , 2010, PAIN®.
[27] F. Cunha,et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice , 2010, PAIN.
[28] D. Frommhold,et al. Critical role of phospholipase Cγ2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis , 2009, The Journal of experimental medicine.
[29] C. Libert,et al. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation , 2007, Journal of leukocyte biology.
[30] P. Klimiuk,et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. , 2006, The Journal of rheumatology.
[31] Michael C. Wendl,et al. Argonaute—a database for gene regulation by mammalian microRNAs , 2005, BMC Bioinformatics.
[32] Hajime Mishima,et al. Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[33] S. Grässel,et al. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. , 2004, Experimental cell research.
[34] M. Pytlik,et al. Effects of Doxycycline on Mechanical Properties of Bones in Rats with Ovariectomy-Induced Osteopenia , 2004, Calcified Tissue International.
[35] M. Zabala,et al. Rapid and simple determination of doxycycline in serum by high-performance liquid chromatography. Application to particulate drug delivery systems. , 2004, Journal of chromatography. A.
[36] F. Breedveld,et al. Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[37] R. Toes,et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 , 2002, Annals of the rheumatic diseases.
[38] Shigeyoshi Itohara,et al. The Role of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Antibody-Induced Arthritis , 2002, The Journal of Immunology.
[39] B. Baxter,et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. , 2002, Journal of vascular surgery.
[40] J. Engler,et al. Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. , 2000, Biochimica et biophysica acta.
[41] Y. Okada,et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis , 2000, Annals of the rheumatic diseases.
[42] J. V. van Meurs,et al. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. , 1999, Arthritis and rheumatism.
[43] P. Petrow,et al. Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[44] K. Brandt,et al. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. , 1999, Arthritis and rheumatism.
[45] K. Rajewsky,et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.
[46] W. Giannobile,et al. Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms , 1998, Advances in dental research.
[47] P. Vadas,et al. Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2. , 1998, The Journal of rheumatology.
[48] S. Santavirta,et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. , 1997, Arthritis and rheumatism.
[49] R. Heller,et al. Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes* , 1996, The Journal of Biological Chemistry.
[50] A. Koch,et al. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. , 1996, Arthritis and rheumatism.
[51] C. López-Otín,et al. Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.
[52] J. Pelletier,et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. , 1996, The Journal of clinical investigation.
[53] D. Wernicke,et al. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. , 1996, The Journal of rheumatology.
[54] K. Geoghegan,et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.
[55] J. Delaissé,et al. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. , 1995, Journal of cell science.
[56] C. López-Otín,et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. , 1994, The Journal of biological chemistry.
[57] P. Vadas,et al. Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. , 1992, Biochemical pharmacology.
[58] L. Golub,et al. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. , 1992, The Journal of rheumatology.
[59] A. Eisen,et al. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. Laskin,et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. , 1987, The Journal of rheumatology.
[61] Y. Okada,et al. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. , 1986, The Journal of biological chemistry.
[62] Renay Gloria. Lights and Shadows , 1897, The Journal of Comparative Medicine and Veterinary Archives.
[63] Bálint Botz,et al. Hydrophobic cyanine dye-doped micelles for optical in vivo imaging of plasma leakage and vascular disruption , 2015, Journal of biomedical optics.
[64] Xun Li,et al. An updated patent therapeutic agents targeting MMPs. , 2012, Recent patents on anti-cancer drug discovery.
[65] C. Brinckerhoff,et al. Matrix metalloproteinases: role in arthritis. , 2006, Frontiers in bioscience : a journal and virtual library.
[66] T. Aigner,et al. MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. , 2004, Clinical and experimental rheumatology.
[67] Michael J. Green,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. , 2003, Rheumatology.
[68] J. Mudgett,et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. , 1998, Arthritis and rheumatism.